Conatus Pharmaceuticals Investors

28 investors on Angel Roster list Conatus Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the Netherlands and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Conatus Pharmaceuticals can appear together.

Investors listed
28
With verified email
32%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 28 Conatus Pharmaceuticals investors

The most complete profiles first. Showing 28 of 28.

  • Peter BainesVerified

    Venture Capital, Investor · United Kingdom

    SeedHealth CareE-commerceCybersecurityDeepTech

    Portfolio: Catalyst Biosciences, Vitrue, Am-Beo, Thiakis and 53 more

    Verified email available

  • paul klingensteinVerified

    Venture Capital · United States

    Series BSeries AHealth CareWearablesHospitalsWellness

    Portfolio: Alibris, goBalto, Kit Check, Eledon Pharmaceuticals and 32 more

    Verified email available

  • Boyd RuttenVerified

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Verified email available

  • Brian GoodmanVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • David BeierVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Verified email available

  • Henry ZubaidaVerified

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Verified email available

  • Luke EvninVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Shinichiro FuseVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Todd FoleyVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Ed Hurwitz

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more

    Contact details available

  • Stephen Curtis

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Christiana Bardon M.D.

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsInvestment ManagementLife Science

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Dan Secor

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Dayton Misfeldt

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Edward Hanlon

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Edwin de Graaf

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Fred Craves

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Jasper van Gorp

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Joep Heldens

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Leigh Zawel

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Matt Kronmiller

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Redmar Koene

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Sanne de Jongh

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Stefan Luzi, PhD

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Tom Klein Robbenhaar

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Contact details available

  • Vinay Bhaskar

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • carl goldfischer

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Jim Scopa

    Venture Capital · United States

    Biotechnology

    Portfolio: Conatus Pharmaceuticals, TriVascular

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Conatus Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 28 Conatus Pharmaceuticals investors. 9 of them (32%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (28), Private Equity Firms (20) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Conatus Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Seed (3), Series B (1) and Series A (1).

Where are Conatus Pharmaceuticals investors based?

Most are based in the United States (18), the Netherlands (8) and the United Kingdom (2).

Which companies have Conatus Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Nevro (15), Agendia (11), Stepping Stones Home & Care (11), Vapotherm (11) and Lumeon (11).

How do I contact Conatus Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 28, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.